Nuwellis (NUWE) EBT Margin (2013 - 2026)

Nuwellis (NUWE) posted EBT Margin of 188.97% for Q1 2026, down 89.13% on a QoQ basis from 99.92% in Q4 2025, and down 3073.0% year-over-year from 6.36% in Q1 2025.

Nuwellis (NUWE) EBT Margin (2013 - 2026) Analysis & Trends

Nuwellis' EBT Margin history runs 14 years deep, the most recent figure standing at 188.97% for Q1 2026.

  • Quarterly EBT Margin fell 3073.0% year-over-year to 188.97% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 217.17% (down 10513.0% YoY) and the FY2025 annual result came in at 211.8%, down 8411.0% from the prior year.
  • EBT Margin was 188.97% for Q1 2026 at Nuwellis, down from 99.92% in the prior quarter.
  • Across five years, EBT Margin topped out at 99.62% in Q3 2024 and bottomed at 727.48% in Q2 2025.
  • A 5-year average of 196.64% and a median of 188.97% in 2026 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2022 — EBT Margin plunged 101142 bps — and 2024, when it surged 23925 bps.
  • Nuwellis' EBT Margin stood at 82.43% in 2022, then slumped by 163 bps to 217.13% in 2023, then soared by 71 bps to 63.18% in 2024, then sank by 58 bps to 99.92% in 2025, then tumbled by 89 bps to 188.97% in 2026.
  • Business Quant data shows NUWE's EBT Margin at 188.97% in Q1 2026, 99.92% in Q4 2025, and 21.11% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 12.98%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 14.12%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 18.70%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 27.84%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 22.61%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 4.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 9.84%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Nuwellis 613.80 -2.08 Mn 1.68 Mn -188.97%

Historic Data

Download Data
DateValue
Mar 31, 2026 -188.97%
Dec 31, 2025 -99.92%
Sep 30, 2025 21.11%
Jun 30, 2025 -727.48%
Mar 31, 2025 -158.25%
Dec 31, 2024 -63.18%
Sep 30, 2024 99.62%
Jun 30, 2024 -352.01%
Mar 31, 2024 -233.06%
Dec 31, 2023 -217.13%
Sep 30, 2023 -139.64%
Jun 30, 2023 -233.40%
Mar 31, 2023 -355.04%
Dec 31, 2022 -82.43%
Sep 30, 2022 -187.31%
Jun 30, 2022 -193.58%
Mar 31, 2022 -232.14%
Dec 31, 2021 928.99%
Sep 30, 2021 -284.40%
Jun 30, 2021 -188.52%